Management of Transplant-Ineligible Multiple Myeloma
SWOG - S2209- VRD-Lite Vs DRd-R Vs DRd-DR - Multiple Myeloma Clinical Trials
Combination Regimens for Multiple Myeloma Show Efficacy in the Transplant-Ineligible Population, According to Dingli
NCCN Guidelines® Insights: Multiple Myeloma, Version 3.2022 in: Journal of the National Comprehensive Cancer Network Volume 20 Issue 1 (2022)
移植非適応での多発性骨髄腫に対するRVD lite(A Phase 2 Study of Modified Lenalidomide, Bortezomib and Dexamethasone in Transplant-Ineligible Multiple Myeloma ) - はくいのてんしちゃん論文編
The efficacy and safety of modified bortezomib‐lenalidomide‐dexamethasone in transplant‐eligible patients with newly diagnosed multiple myeloma - Okazuka - 2020 - European Journal of Haematology - Wiley Online Library
Short overview on the current standard of treatment in newly diagnosed multiple myeloma | SpringerLink
Longer term follow-up of the randomized phase III trial SWOG S0777: bortezomib, lenalidomide and dexamethasone vs. lenalidomide and dexamethasone in patients (Pts) with previously untreated multiple myeloma without an intent for immediate
Treatment Considerations for Transplant-Ineligible Multiple Myeloma
PDF) Longer term follow-up of the randomized phase III trial SWOG S0777: bortezomib, lenalidomide and dexamethasone vs. lenalidomide and dexamethasone in patients (Pts) with previously untreated multiple myeloma without an intent for
Daratumumab Forms Backbone of Triplet Regimens in Transplant Ineligible Multiple Myeloma
Combination Regimens for Multiple Myeloma Show Efficacy in the Transplant-Ineligible Population, According to Dingli
Treatment Considerations for Transplant-Ineligible Multiple Myeloma
Designing a Therapy Sequence for the Treatment of Multiple Myeloma
Cancers | Free Full-Text | Pursuing a Curative Approach in Multiple Myeloma: A Review of New Therapeutic Strategies | HTML
How I manage frontline transplant-ineligible multiple myeloma | Hematology Reports
The efficacy and safety of modified bortezomib‐lenalidomide‐dexamethasone in transplant‐eligible patients with newly diagnosed multiple myeloma - Okazuka - 2020 - European Journal of Haematology - Wiley Online Library
Multiple myeloma - The Lancet
Lipe Discusses Therapeutic Options for a Patient With Transplant-Ineligible Multiple Myeloma
Updated Perspectives on the Management of Multiple Myeloma in Older Pa | CIA
Primary treatment of light-chain amyloidosis with bortezomib, lenalidomide, and dexamethasone. - Abstract - Europe PMC
ESH 2nd How to Diagnose and Treat Multiple Myeloma 2019 / Twitter
